Molecular Ecology Notes

Wiley
Wiley
ISSN: 14718278, 14718286

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
journal names
Molecular Ecology Notes
Publications
1 904
Citations
89 271
h-index
85
Top-3 citing journals
Molecular Ecology
Molecular Ecology (5019 citations)
Conservation Genetics
Conservation Genetics (3523 citations)
PLoS ONE
PLoS ONE (3496 citations)
Top-3 organizations
University of Tokyo
University of Tokyo (39 publications)
Cornell University
Cornell University (31 publications)
University of Sheffield
University of Sheffield (28 publications)
Top-3 countries
USA (567 publications)
United Kingdom (253 publications)
France (198 publications)

Most cited in 5 years

Found 
from chars
Publications found: 5726
Creating New Cis-Regulatory Elements of HBD to Reactivate Delta-Globin
Chen L., Liu D., Hong W., Xu L., Cheng L., Luo Y., Xu H., Liang J., Fang J., Li X.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Overexpression of ABCA1 in Carotid Endothelium of Hyperlipidemic Rabbits Modulates Vascular Inflammation
Wacker B.K., Bi L., Saenz-Pipaon G., Sanford N., Regan A.Z., Lim N.S., Liu L., Kim F., Dichek D.A.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Evaluation of Purification Methods for Minimizing Transgene Expression Background During Viral Manufacturing
Bento R., Burr A., Teryek M., Parekkadan B.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Encapsulation of a Single-Stranded Form of DNA Impurities into the Capsid of a Recombinant Adeno-Associated Virus
Uchida K., Ito-Kudo E., Higashiyama K., Masumi-Koizumi K., Yusa K., Yuan Y.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations
Chaugule S., Constantinou C.K., John A.A., Micha D., Eekhoff M., Gravallese E., Gao G., Shim J.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Minimally Humanized Ezh2 Exon-18 Mouse Cell Lines Validate Preclinical CRISPR/Cas9 Approach to Treat Weaver Syndrome
Gibson W.T., Lengyell T.C., Korecki A.J., Janssen S.M., Adair B.A., Gamu D., Lorincz M.C., Simpson E.M.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Analysis of HIV-1-Based Lentiviral Vector Particle Composition by PacBio Long-Read Nucleic Acid Sequencing
Suleman S., Khalifa M.S., Fawaz S., Alhaque S., Chinea Y., Themis M.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy Program
Lomash R.M., Dehdashti J., Shchelochkov O.A., Chandler R.J., Li L., Manoli I., Sloan J.L., Terse P., Xu X., Saade D., Stan R., Brooks P.J., Lo D.C., Bönnemann C.G., Venditti C.P., et. al.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
AAV-Mediated Gene Transfer of WDR45 Corrects Neurological Deficits in the Mouse Model of Beta-Propeller Protein-Associated Neurodegeneration
Carisi M.C., Shamber C., Bishop M., Sangster M., Chandrachud U., Meyerink B., Pilaz L.J., Grishchuk Y.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Hum Gene Therapy Briefs March 2025
Philippidis A.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Prevalence of Neutralizing Antibodies to AAV2 and AAV9 in Individuals with Niemann-Pick Disease, Type C1
Mylvara A.V., Davidson C.D., Alexander D., Venditti C.P., Porter F.D.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Central Nervous System-Targeted Gene Therapy for the Treatment of Neurocognitive Deficits in Mucopolysaccharidosis Type II Mice
Chen G., Zhan X., Gao X., Yi M., Liang H., Chen Y., Lin Q., Yang J., Hou S., Maegawa G., Zhang H.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
A Comprehensive Review of Clinically Applied Adeno-Associated Virus-Based Gene Therapies for Ocular Disease
Hinsch V.G., Boye S.L., Boye S.E.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
ESGCT Abstract Author Index
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0

Top-100

Citing journals

1000
2000
3000
4000
5000
6000
Show all (70 more)
1000
2000
3000
4000
5000
6000

Citing publishers

5000
10000
15000
20000
25000
Show all (70 more)
5000
10000
15000
20000
25000

Publishing organizations

5
10
15
20
25
30
35
40
Show all (70 more)
5
10
15
20
25
30
35
40

Publishing countries

100
200
300
400
500
600
USA, 567, 29.78%
United Kingdom, 253, 13.29%
France, 198, 10.4%
Australia, 174, 9.14%
Japan, 136, 7.14%
Germany, 117, 6.14%
China, 116, 6.09%
Canada, 102, 5.36%
Italy, 63, 3.31%
Switzerland, 59, 3.1%
Spain, 56, 2.94%
Brazil, 51, 2.68%
Netherlands, 39, 2.05%
Sweden, 36, 1.89%
Portugal, 29, 1.52%
Belgium, 25, 1.31%
South Africa, 24, 1.26%
Denmark, 21, 1.1%
Republic of Korea, 21, 1.1%
Finland, 20, 1.05%
India, 19, 1%
Mexico, 19, 1%
Singapore, 18, 0.95%
Thailand, 17, 0.89%
Malaysia, 14, 0.74%
New Zealand, 12, 0.63%
Norway, 12, 0.63%
Austria, 11, 0.58%
Czech Republic, 10, 0.53%
Greece, 8, 0.42%
Ireland, 8, 0.42%
Argentina, 7, 0.37%
Panama, 6, 0.32%
Poland, 5, 0.26%
Chile, 5, 0.26%
Russia, 4, 0.21%
Kenya, 4, 0.21%
Colombia, 4, 0.21%
Madagascar, 4, 0.21%
Puerto Rico, 4, 0.21%
Slovenia, 4, 0.21%
Indonesia, 3, 0.16%
Senegal, 3, 0.16%
Philippines, 3, 0.16%
French Polynesia, 3, 0.16%
Ecuador, 3, 0.16%
Hungary, 2, 0.11%
Ghana, 2, 0.11%
Israel, 2, 0.11%
Iran, 2, 0.11%
Iceland, 2, 0.11%
Cameroon, 2, 0.11%
Morocco, 2, 0.11%
Slovakia, 2, 0.11%
Tunisia, 2, 0.11%
Turkey, 2, 0.11%
Kazakhstan, 1, 0.05%
Estonia, 1, 0.05%
Bangladesh, 1, 0.05%
Benin, 1, 0.05%
Burkina Faso, 1, 0.05%
Venezuela, 1, 0.05%
Gabon, 1, 0.05%
Guyana, 1, 0.05%
Georgia, 1, 0.05%
Côte d'Ivoire, 1, 0.05%
Cuba, 1, 0.05%
Mali, 1, 0.05%
Mongolia, 1, 0.05%
New Caledonia, 1, 0.05%
Palestine, 1, 0.05%
Syria, 1, 0.05%
Uganda, 1, 0.05%
Sri Lanka, 1, 0.05%
Show all (44 more)
100
200
300
400
500
600